HealthNews Pulse
Entropy starts 60-minute IV psilocin dosing in phase II binge-eating trial | Stockhead
Entropy Neurodynamics (ASX: ENP) starts Cohort 2 dosing in phase II BED trial of its IV-infused psilocin treatment.
Read the full pulseContinue in Briflio to read, react, comment, and share.
Sources